Refine
Has Fulltext
- yes (24)
Is part of the Bibliography
- yes (24)
Year of publication
- 2015 (24) (remove)
Document Type
- Journal article (24)
Language
- English (24) (remove)
Keywords
- guidelines (3)
- impact (3)
- management (3)
- mortality (3)
- TAVI (2)
- chronic kidney disease (2)
- convection volume (2)
- diagnosis (2)
- echocardiography (2)
- follow-up (2)
- inflammation (2)
- multicenter (2)
- outcomes (2)
- prevalence (2)
- replacement (2)
- risk factors (2)
- sizing (2)
- 2-dimensional speckle tracking (1)
- BRAF(V600E) mutation (1)
- ESC (1)
- European Society (1)
- Family Investigation of Nephropathy and Diabetes (1)
- HEK cells (1)
- KDIGO (1)
- OAT1 (1)
- OAT3 (1)
- OK cells (1)
- United States (1)
- adrenocortical (1)
- alcohol (1)
- anatomy (1)
- anemia (1)
- association (1)
- atherosclerosis risk (1)
- atypical (1)
- avascular necrosis (1)
- balance (1)
- biomarker (1)
- blood (1)
- blood flow (1)
- bone (1)
- cancer (1)
- carcinoma metastases to pancreas (1)
- cardiac magnetic resonance imaging (1)
- cardiovascular events (1)
- cardiovascular magnetic resonance (1)
- cardiovascularm disease (1)
- cells (1)
- cellular physiology (1)
- chronic cerebrovascular disease (1)
- chronic distress (1)
- chronic heart failure (CHF) (1)
- chronic thromboembolic pulmonary hypertension (1)
- cigarette smoking (1)
- clinical manifestations (1)
- cloning of putative human promoter sequence (1)
- colloids (1)
- complex (1)
- comprehensive psychosomatic assessment (1)
- consensus conference (1)
- cortical OAT1 (1)
- costs (1)
- creatinine (1)
- diabetes mellitus (1)
- diabetic kidney disease (1)
- dialysis (1)
- dimensions (1)
- disease (1)
- dissection (1)
- distant metastases (1)
- down regulation (1)
- early-stage osteonecrosis (1)
- end-stage renal disease (1)
- epidemiology (1)
- ferritin (1)
- fibroblast growth factor-23 (1)
- fibrosis (1)
- gastric cancer (1)
- gene-environment interaction (1)
- genome-wide association study (1)
- global outcomes (1)
- glomerular filtration rate (1)
- haemodiafiltration (1)
- health economics (1)
- hemodiafiltration (1)
- hemodialysis (1)
- hemoglobin (1)
- histopathology (1)
- home telemonitoring (1)
- hypertrophic cardiomyopathy (1)
- identification (1)
- idiopathic osteonecrosis (1)
- immune cells (1)
- implantation (1)
- incidence (1)
- incremental cost-effectiveness ratio (ICER) (1)
- insufficiency (1)
- intake (1)
- ischemia (1)
- ischemic acute kidney injury model (1)
- ischemic stroke (1)
- kidneys (1)
- left lateral wall (1)
- left ventricular hypertrophy (1)
- leukocytes (1)
- lymphocytes (1)
- marrow (1)
- men born (1)
- metaanalysis (1)
- metachronous (1)
- mineral metabolism (1)
- monocytes (1)
- multidetector computed-tomography (1)
- myocardial infarction (1)
- nitric oxide (1)
- nontraumatic osteonecrosis of the femoral head (1)
- occupational-status (1)
- opossum kidney cells (1)
- papillary (1)
- parathyroid hormone (1)
- paravalvular regurgitation (1)
- perioperative chemotherapy (1)
- peritoneal carcinomatosis (1)
- phosphate homeostasis (1)
- polarization (1)
- prostaglandin e2 (1)
- proteinuria (1)
- radioiodine therapy (1)
- recommendations (1)
- recurrence survival (1)
- recurrent Tako-Tsubo cardiomyopathy (1)
- regulation of expression (1)
- regulatory T cells (1)
- regurgitation (1)
- renal replacement therapy (1)
- reperfusion (1)
- reporter gen assay (1)
- root (1)
- safety (1)
- sepsis (1)
- stenosis (1)
- surgery (1)
- surgical treatment (1)
- survival (1)
- telemedicine (1)
- therapy (1)
- thromboinflammation (1)
- tomography (1)
- transgenic rats (1)
- translation (1)
- transport experiments (1)
- tricuspid pressure gradient (1)
- type 2 diabetes (1)
- urine (1)
Institute
- Medizinische Klinik und Poliklinik I (24) (remove)
In post-dilution online haemodiafiltration (ol-HDF), a relationship has been demonstrated between the magnitude of the convection volume and survival. However, to achieve high convection volumes (>22 L per session) detailed notion of its determining factors is highly desirable. This manuscript summarizes practical problems and pitfalls that were encountered during the quest for high convection volumes. Specifically, it addresses issues such as type of vascular access, needles, blood flow rate, recirculation, filtration fraction, anticoagulation and dialysers. Finally, five of the main HDF systems in Europe are briefly described as far as HDF prescription and optimization of the convection volume is concerned.
Background
In patients undergoing maintenance hemodialysis (HD), increased levels of circulating fibroblast growth factor-23 (FGF-23) are independently associated with cardiovascular events and mortality. Interventional strategies aiming to reduce levels of FGF-23 in HD patients are of particular interest. The purpose of the current study was to compare the impact of high-flux versus low-flux HD on circulating FGF-23 levels.
Methods
We conducted a post-hoc analysis of the MINOXIS study, including 127 dialysis patients randomized to low-flux (n = 62) and high-flux (n = 65) HD for 52 weeks. Patients with valid measures for FGF-23 investigated baseline and after 52 weeks were included.
Results
Compared to baseline, a significant increase in FGF-23 levels after one year of low-flux HD was observed (Delta plasma FGF-23: +4026 RU/ml; p < 0.001). In contrast, FGF-23 levels remained stable in the high flux group (Delta plasma FGF-23: +373 RU/ml, p = 0.70). The adjusted difference of the absolute change in FGF-23 levels between the two treatment groups was statistically significant (p < 0.01).
Conclusions
Over a period of 12 months, high-flux HD was associated with stable FGF-23 levels, whereas the low-flux HD group showed an increase of FGF-23. However, the implications of the different FGF 23 time-trends in patients on high flux dialysis, as compared to the control group, remain to be explored in specifically designed clinical trials.
Background and Aims
Chronic kidney disease (CKD) is a risk factor for development and progression of heart failure (HF). CKD and HF share common risk factors, but few data exist on the prevalence, signs and symptoms as well as correlates of HF in populations with CKD of moderate severity. We therefore aimed to examine the prevalence and correlates of HF in the German Chronic Kidney Disease (GCKD) study, a large observational prospective study.
Methods and Results
We analyzed data from 5,015 GCKD patients aged 18-74 years with an estimated glomerular filtration rate (eGFR) of <60 ml/min/1.73m\(^{2}\) or with an eGFR >= 60 and overt proteinuria (>500 mg/d). We evaluated a definition of HF based on the Gothenburg score, a clinical HF score used in epidemiological studies (Gothenburg HF), and self-reported HF. Factors associated with HF were identified using multivariable adjusted logistic regression. The prevalence of Gothenburg HF was 43% (ranging from 24% in those with eGFR >90 to 59% in those with eGFR<30 ml/min/1.73m2). The corresponding estimate for self-reported HF was 18% (range 5%-24%). Lower eGFR was significantly and independently associated with the Gothenburg definition of HF (p-trend <0.001). Additional significantly associated correlates included older age, female gender, higher BMI, hypertension, diabetes mellitus, valvular heart disease, anemia, sleep apnea, and lower educational status.
Conclusions
The burden of self-reported and Gothenburg HF among patients with CKD is high. The proportion of patients who meet the criteria for Gothenburg HF in a European cohort of patients with moderate CKD is more than twice as high as the prevalence of self-reported HF. However, because of the shared signs, symptoms and medications of HF and CKD, the Gothenburg score cannot be used to reliably define HF in CKD patients. Our results emphasize the need for early screening for HF in patients with CKD.
Background:
Evidence that home telemonitoring for patients with chronic heart failure (CHF) offers clinical benefit over usual care is controversial as is evidence of a health economic advantage.
Methods:
Between January 2010 and June 2013, patients with a confirmed diagnosis of CHF were enrolled and randomly assigned to 2 study groups comprising usual care with and without an interactive bi-directional remote monitoring system (Motiva\(^{®}\)). The primary endpoint in CardioBBEAT is the Incremental Cost-Effectiveness Ratio (ICER) established by the groups' difference in total cost and in the combined clinical endpoint "days alive and not in hospital nor inpatient care per potential days in study" within the follow-up of 12 months.
Results:
A total of 621 predominantly male patients were enrolled, whereof 302 patients were assigned to the intervention group and 319 to the control group. Ischemic cardiomyopathy was the leading cause of heart failure. Despite randomization, subjects of the control group were more often in NYHA functional class III-IV, and exhibited peripheral edema and renal dysfunction more often. Additionally, the control and intervention groups differed in heart rhythm disorders. No differences existed regarding risk factor profile, comorbidities, echocardiographic parameters, especially left ventricular and diastolic diameter and ejection fraction, as well as functional test results, medication and quality of life. While the observed baseline differences may well be a play of chance, they are of clinical relevance. Therefore, the statistical analysis plan was extended to include adjusted analyses with respect to the baseline imbalances.
Conclusions:
CardioBBEAT provides prospective outcome data on both, clinical and health economic impact of home telemonitoring in CHF. The study differs by the use of a high evidence level randomized controlled trial (RCT) design along with actual cost data obtained from health insurance companies. Its results are conducive to informed political and economic decision-making with regard to home telemonitoring solutions as an option for health care. Overall, it contributes to developing advanced health economic evaluation instruments to be deployed within the specific context of the German Health Care System.